VERNON HILLS, Ill.--(BUSINESS WIRE)--Applied NeuroSolutions, Inc. (OTC BB:APNS)(www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease (“AD”), today announced it has engaged William Blair & Company, LLC in connection with the Company’s ongoing process to explore strategic alternatives to enhance shareholder value.
